Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent

Science of the Total Environment

Volumn 466-467, Issue , 2014, Pages 976-984

  Du, Bowen ^a   Price, Amy E ^a   Scott, W Casan ^a   Kristofco, Lauren A ^a   Ramirez, Alejandro J ^a   Chambliss, C Kevin ^a   Yelderman, Joe C ^a   Brooks, Bryan W ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Decentralized wastewater treatment; Effluent; Pharmaceuticals; Wastewater indicators; Water quality

Indexed keywords

CARBONACEOUS BIOCHEMICAL OXYGEN DEMANDS; CONTAMINANTS OF EMERGING CONCERNS; DECENTRALIZED WASTEWATER; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MUNICIPAL WASTEWATER TREATMENT PLANTS; ON-SITE WASTEWATER TREATMENT SYSTEMS; SUBSURFACE FLOW CONSTRUCTED WETLANDS; WASTEWATER INDICATORS;

BIOCHEMICAL OXYGEN DEMAND; DRUG PRODUCTS; EFFLUENT TREATMENT; HAZARDS; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RECLAMATION; WASTEWATER TREATMENT; WATER QUALITY;

EFFLUENTS;

ATENOLOL; BENZOYLECGONINE; CAFFEINE; CARBAMAZEPINE; CELECOXIB; CODEINE; DIAZEPAM; DICLOFENAC; DILTIAZEM; DIPHENHYDRAMINE; ERYTHROMYCIN; GEMFIBROZIL; METHYLPHENIDATE; PARACETAMOL; PROPRANOLOL; SUCRALOSE; SULFAMETHOXAZOLE; TRIMETHOPRIM; WARFARIN; DRUG; WATER POLLUTANT;

BIOCHEMICAL OXYGEN DEMAND; COMPARATIVE STUDY; DRUG; EFFLUENT; EXPERIMENTAL STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUNICIPAL SOLID WASTE; SEWAGE TREATMENT; WASTEWATER; WATER QUALITY;

ARTICLE; BIOCHEMICAL OXYGEN DEMAND; DECENTRALIZATION; DILUTION; EFFLUENT; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SOIL TREATMENT; TANDEM MASS SPECTROMETRY; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; WATER QUALITY; ANALYSIS; ANIMAL; BLOOD; COMPARATIVE STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FISH; METABOLISM; SEASON; SEWAGE; UNITED STATES; WATER POLLUTANT;

ANIMALS; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FISHES; PHARMACEUTICAL PREPARATIONS; SEASONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TEXAS; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER QUALITY;

EID: 84883009377     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.07.126     Document Type: Article

References (74)

1. Allergy & Asthma Center [Austin, TX, USA]. http://www.aactx.com/pollencount/index.php.
2. American Housing Survey Table 1-4 selected equipment and plumbing - all housing units. U.S. A. Bureau (Ed.), Current Housing Report Series. Washington, DC; 2011.
3. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
4. Ankley G.T., Brooks B.W., Huggett D.B., Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environ Sci Technol 2007, 41:8211-8217.
5. Antweiler R.C., Taylor H.E. Evaluation of statistical treatments of left-censored environmental data using coincident uncensored data sets: I. Summary statistics. Environ Sci Technol 2008, 42:3732-3738.
6. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 2004, 333:167-184.
7. Berninger J.P., Brooks B.W. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 2010, 193:69-78.
8. Berninger J.P., Du B., Connors K.A., Eytcheson S.A., Kolkmeier M.A., Prosser K.N., et al. Effects of the antihistamine diphenhydramine on selected aquatic organisms. Environ Toxicol Chem 2011, 30:2065-2072.
9. Boxall A.B., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
10. Brooks B.W., Scott J.T., Forbes M.G., Valenti T.W., Stanley J.K., Doyle R.D., et al. Reservoir zonation and water quality: science, management and regulations. Lakeline 2008, 28:39-43.
11. Brooks B.W., Huggett D.B., Boxall A.B.A. Pharmaceuticals and personal care products: research needs for the next decade. Environ Toxicol Chem 2009, 28:2469-2472.
12. Brooks B.W., Chambliss C.K., Sedlak D.L., Knight R.L. Evaluate wetland systems for treated wastewater performance to meet competing effluent water quality goals. Water reuse research foundation 2011.
13. Carrara C., Ptacek C.J., Robertson W.D., Blowes D.W., Moncur M.C., Sverko E., et al. Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environ Sci Technol 2008, 42:2805-2811.
14. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 2004, 38:947-954.
15. Code of Federal Regulations Definition and procedure for the determination of the method detection limit. Title 40, section 136, appendix B 1986.
16. Conn K.E., Barber L.B., Brown G.K., Siegrist R.L. Occurrence and fate of organic contaminants during onsite wastewater treatment. Environ Sci Technol 2006, 40:7358-7366.
17. Conn K.E., Siegrist R.L., Barber L.B., Meyer M.T. Fate of trace organic compounds during vadose zone soil treatment in an onsite wastewater system. Environ Toxicol Chem 2010, 29:285-293.
18. Connors K.A., Du B., Fitzsimmons P.N., Hoffman A.D., Chambliss C.K., Nichols J.W., et al. Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions. Environ Toxicol Chem 2013, 32:1810-1818.
19. Daughton C., Brooks B. Active pharmaceutical ingredients and aquatic organisms. Environmental contaminants in biota 2011, CRC Press, Taylor and Francis, Boca Raton. J.M. WN Beyer (Ed.).
20. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
21. Davila P. The evaluation of a subsurface-flow constructed wetland for on-site wastewater treatment under the NSF/ANSI standard 40 protocol design loading. Department of Environmental Science 2006, Baylor University, Waco, TX.
22. Du B., Perez-Hurtado P., Brooks B.W., Chambliss C.K. Evaluation of an isotope dilution liquid chromatography tandem mass spectrometry method for pharmaceuticals in fish. J Chromatogr A 2012, 1253:177-183.
23. Erickson R.J., McKim J.M., Lien G.J., Hoffman A.D., Batterman S.L. Uptake and elimination of ionizable organic chemicals at fish gills: I. Model formulation, parameterization, and behavior. Environ Toxicol Chem 2006, 25:1512-1521.
24. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ Sci Technol 2010, 44:2661-2666.
25. Fick J., Lindberg R.H., Tysklind M., Larsson D.G.J. Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 2010, 58:516-523.
26. Fitzsimmons P.N., Fernandez J.D., Hoffman A.D., Butterworth B.C., Nichols J.W. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2001, 55:23-34.
27. Fram M.S., Belitz K. Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci Total Environ 2011, 409:3409-3417.
28. Garcia S.N., Clubbs R.L., Stanley J.K., Scheffe B., Yelderman J.C., Brooks B.W. Comparative analysis of effluent water quality from a municipal treatment plant and two on-site wastewater treatment systems. Chemosphere 2013, 92:38-44.
29. Gheorghe A., van Nuijs A., Pecceu B., Bervoets L., Jorens P., Blust R., et al. Analysis of cocaine and its principal metabolites in waste and surface water using solid-phase extraction and liquid chromatography-ion trap tandem mass spectrometry. Anal Bioanal Chem 2008, 391:1309-1319.
30. Godfrey E., Woessner W.W., Benotti M.J. Pharmaceuticals in on-site sewage effluent and ground water, western Montana. Ground Water 2007, 45:263-271.
31. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 2008, 42:5807-5813.
32. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-393.
33. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002, 131:5-17.
34. Hijosa-Valsero M., Matamoros V., Martín-Villacorta J., Bécares E., Bayona J.M. Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Res 2010, 44:1429-1439.
35. Hinkle S.R., Weick R.j, Johnson J.M., Cahill J.D., Smith S.G., Rich B.J. Organic wastewater compounds, pharmaceuticals, and coliphage in ground water receiving discharge from onsite wastewater treatment systems near La Pine, Oregon: occurrence and implications for transport. USGS Scientific Investigations Report 2005-5055 2005, USGS, Reston, Virginia.
36. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 2003, 9:1789-1799.
37. Kadlec R.H., Knight R.I. Treatment wetlands 1996, CRC Press LLC, Boca Raton, FL.
38. Kinyua J., Anderson T.A. Temporal analysis of the cocaine metabolite benzoylecgonine in wastewater to estimate community drug use. J Forensic Sci 2012, 57:1349-1353.
39. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
40. Letzel M., Weiss K., Schüssler W., Sengl M. Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system. Chemosphere 2010, 81:1416-1422.
41. Loos R., Gawlik B.M., Boettcher K., Locoro G., Contini S., Bidoglio G. Sucralose screening in European surface waters using a solid-phase extraction-liquid chromatography-triple quadrupole mass spectrometry method. J Chromatogr A 2009, 1216:1126-1131.
42. Lowe K., Van Cuyk S., Siegrist R., Drewes J. Field evaluation of the performance of engineered on-site wastewater treatment units. J Hydrol Eng 2008, 13:735-743.
43. MacLeod S.L., Wong C.S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res 2010, 44:533-544.
44. Martindale The complete drug reference 2002, Pharmaceutical Press Royal Pharmaceutical Society, London, UK.
45. Matamoros V., Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ Sci Technol 2006, 40:5811-5816.
46. Matamoros V., García J., Bayona J.M. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environ Sci Technol 2005, 39:5449-5454.
47. Mawhinney D.B., Young R.B., Vanderford B.J., Borch T., Snyder S.A. Artificial sweetener sucralose in U.S. drinking water systems. Environ Sci Technol 2011, 45:8716-8722.
48. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ Pollut 2012, 165:250-258.
49. Metcalfe C., Tindale K., Li H., Rodayan A., Yargeau V. Illicit drugs in Canadian municipal wastewater and estimates of community drug use. Environ Pollut 2010, 158:3179-3185.
50. NSF International NSF/ANSI residential wastewater treatment systems [http://www.nsf.org/Certified/Wastewater/Listings.asp?TradeName=&Standard=040].
51. Oppenheimer J., Eaton A., Badruzzaman M., Haghani A.W., Jacangelo J.G. Occurrence and suitability of sucralose as an indicator compound of wastewater loading to surface waters in urbanized regions. Water Res 2011, 45:4019-4027.
52. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environ Sci Technol 2010, 44:6289-6296.
53. Radjenović J., Petrović M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
54. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal Chem 2007, 79:3155-3163.
55. Scheurer M., Brauch H.-J., Lange F. Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT). Anal Bioanal Chem 2009, 394:1585-1594.
56. Schreiber R., Gündel U., Franz S., Küster A., Rechenberg B., Altenburger R. Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data. Regul Toxicol Pharmacol 2011, 61:261-275.
57. Schulz M., Iwersen-Bergmann S., Andresen H., Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 2012, 16:1-4.
58. Seiler R.L., Zaugg S.D., Thomas J.M., Howcroft D.L. Caffeine and pharmaceuticals as indicators of waste water contamination in wells. Ground Water 1999, 37:405-410.
59. Soh L., Connors K.A., Brooks B.W., Zimmerman J. Fate of sucralose through environmental and water treatment processes and impact on plant indicator species. Environ Sci Technol 2011, 45:1363-1369.
60. Standley L.J., Rudel R.A., Swartz C.H., Attfield K.R., Christian J., Erickson M., et al. Wastewater-contaminated groundwater as a source of endogenous hormones and pharmaceuticals to surface water ecosystems. Environ Toxicol Chem 2008, 27:2457-2468.
61. Stanford B.D., Weinberg H.S. Evaluation of on-site wastewater treatment technology to remove estrogens, nonylphenols, and estrogenic activity from wastewater. Environ Sci Technol 2010, 44:2994-3001.
62. Swartz C.H., Reddy S., Benotti M.J., Yin H., Barber L.B., Brownawell B.J., et al. Steroid estrogens, nonylphenol ethoxylate metabolites, and other wastewater contaminants in groundwater affected by a residential septic system on Cape Cod, MA. Environ Sci Technol 2006, 40:4894-4902.
63. Teerlink J., Martínez-Hernández V., Higgins C.P., Drewes J.E. Removal of trace organic chemicals in onsite wastewater soil treatment units: a laboratory experiment. Water Res 2012, 46:5174-5184.
64. Texas Natural Resources Conservation Commission Chapter 285 On-Site Sewage Facilities. in: Texas Administrative Code, ed. 30. Austin, TX, USA; 2002b.
65. Thomas K.V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R., et al. Comparing illicit drug use in 19 European cities through sewage analysis. Sci Total Environ 2012, 432:432-439.
66. U.S. EPA. On-site wastewater treatment systems manual 2002, [Washington DC, USA]. Office of Water Office of Research and Development (Ed.).
67. U.S. EPA Handbook for managing on-site and clustered (decentralized) wastewater treatment systems: an introduction to management tools and information for implementing EPA's management guidelines 2005, [Washington, DC, USA]. U.S. EPA (Ed.).
68. U.S. FDA Maximum recommended therapeutic dose (MRTD) database 2009, MD: Office of Pharmaceutical Science, Silver Spring.
69. Valenti T.W., Gould G.G., Berninger J.P., Connors K.A., Keele N.B., Prosser K.N., et al. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. Environ Sci Technol 2012, 46:2427-2435.
70. Van Cuyk S., Siegrist R., Logan A., Masson S., Fischer E., Figueroa L. Hydraulic and purification behaviors and their interactions during wastewater treatment in soil infiltration systems. Water Res 2001, 35:953-964.
71. van Nuijs A.L.N., Castiglioni S., Tarcomnicu I., Postigo C., de Alda M.L., Neels H., et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci Total Environ 2011, 409:3564-3577.
72. Vanderford B.J., Snyder S.A. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 2006, 40:7312-7320.
73. Wilcox J.D., Bahr J.M., Hedman C.J., Hemming J.D.C., Barman M.A.E., Bradbury K.R. Removal of organic wastewater contaminants in septic systems using advanced treatment technologies all rights reserved. No part of this periodical may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. J Environ Qual 2009, 38:149-156.
74. Wu C., Spongberg A., Witter J., Fang M., Czajkowski K., Ames A. Dissipation and leaching potential of selected pharmaceutically active compounds in soils amended with biosolids. Arch Environ Contam Toxicol 2010, 59:343-351.